Simpson, E., J. Merola, J. Silverberg, R. Zachariae, R. Olsen, and A. Wollenberg. “Safety of Specifically Targeting Interleukin 13 With Tralokinumab in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Pooled Analysis of Five Randomized, Double-Blind, Placebo-Controlled Phase 3 and Phase 2 Trials”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 1, Jan. 2021, p. s11, doi:10.25251/skin.5.supp.11.